<DOC>
	<DOCNO>NCT01001806</DOCNO>
	<brief_summary>Approximately 126 subject schedule undergo cataract surgery phacoemulsification , randomize even allocation ( 1:1:1 ) either Acuvail , Xibrom , Nevanac . Subjects instruct begin dose study medication operative eye day surgery continue dose day surgery . Beginning one hour surgery , 1 drop study medication instill operating room staff approximately every 15 minute total 3 dos . At designated time paracentesis perform start cataract procedure least 0.15 cc aqueous humor collect . The sample immediately store dry ice ship laboratory analysis .</brief_summary>
	<brief_title>A Comparison Peak Aqueous Penetration Acuvail ( Ketorolac 0.45 % ) , Xibrom ( Bromfenac 0.09 % ) , Nevanac ( Nepafenac 0.1 % ) Patients Undergoing Phacoemulsification</brief_title>
	<detailed_description />
	<mesh_term>Cataract</mesh_term>
	<mesh_term>Bromfenac</mesh_term>
	<mesh_term>Ketorolac</mesh_term>
	<mesh_term>Ketorolac Tromethamine</mesh_term>
	<mesh_term>Nepafenac</mesh_term>
	<criteria>Subjects must 18 year age old . Scheduled cataract surgery phacoemulsification . Subject must willing comply study requirement willing give inform consent . Any subject history uveitis active iritis . Subject previous eye surgery , exception refractive surgery , within 6 month . No ocular use prostaglandin within 2 week surgery . Use oral , injectable topical ophthalmic steroid , nonsteroidal antiinflammatory ( NSAIDS ) immunosuppressant within 14 day prior surgery . Contraindications NSAIDS . Active ocular infection .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
</DOC>